Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...

Investigators studied cancer incidence, survival outcomes, and graft function among a multicenter cohort of kidney transplant recipients.

Researchers evaluated opioid prescribing trends by provider type for emergency department visits at noninstitutional and short-stay hospitals from 2019 to 2021.

HealthDay News — Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology Rehabilitation and Exercise) is feasible ...

Pediatric patients with angiosarcoma were found to have a higher survival rate than their adult counterparts and may benefit from more aggressive treatments.

A pooled analysis of individual data from 5 COG studies demonstrated that race/ethnicity has no significant effect on survival for children and AYAs with cancer receiving treatment on clinical trial.

Interventions for sleep latency and daytime dysfunction can break the chained symptom interaction between sleep and cancer-related fatigue.

The risk of mortality for patients with colon cancer is significantly higher for those with cannabis-use disorder, compared with use disorders of other substances.

Recent novel treatments for chronic lymphocytic leukemia (CLL), such as second-generation covalent Bruton tyrosine kinase inhibitors (cBTKis) and venetoclax-obinutuzumab (VenO), may offer better ...

Overall survival after HCT for high-risk features in patients with SDS was superior to OS for HCT for MDS/AML, particularly ...

Results of a randomized, placebo-controlled study demonstrated avatrombopag achieved the primary endpoint of platelet response in heavily pretreated pediatric patients with persistent or chronic ITP.